Britain MPs complain about Tamiflu; Teva releases generic Detrol; Pain pandemic blamed on opioid restrictions;

@FiercePharma: Rakesh Bamzai Joins Mylan as President, India Commercial and Emerging Markets. Release | Follow @FiercePharma

@EricPFierce: Merck is cutting 150 in its Saphris sales team after selling the drug to Forest for $240M. More | Follow @EricPFierce

@CarlyHFierce: Cue more drama in Teva's boardroom as its CEO announcement nears. Yesterday's story | Follow @CarlyHFierce

> Members of Britain's Parliament continue to expresss displeasure over how much the goverment has spent on Roche's Tamiflu, given the questions over its effectiveness. Story

> Johnson & Johnson's ($JNJ) newest plant in China will be its first in the western part of the country. Report

> Teva Pharmaceutical Industries ($TEVA) has launched an authorized generic of Pfizer's ($PFE) incontinence drug Detrol. Release

> Boehringer Ingelheim is buying more real estate in Columbus, OH. Report

> Spanish blood products group Grifols has gotten a $1.5 billion bridge loan to assist with its buyout of the blood transfusion testing unit of Novartis ($NVS). Item

Medical Device News

@FierceMedDev: The CFO of troubled Mela Sciences resigned on Dec. 31. CEO Rose Crane is filling in. Release | Follow @FierceMedDev

@MichaelGFierce: Gene therapy technique from Washington University in St. Louis targets tumor blood vessels. Article | Follow @MichaelGFierce

@GalenMoore: Drug companies accused of holding back complete information on clinical trials. Story | Follow @GalenMoore

> Nipro is recalling glucose meters over a display mixup. More

> Quidel entices investors with FDA thumbs-up for strep test. News

> Boston Scientific looks to follow up on a big 2013. Report

Biotech News

@FierceBiotech: Marina Biotech, Mirna Therapeutics amend license deal to develop microRNA-based therapeutics. Release | Follow @FierceBiotech

@JohnCFierce: Top FierceBiotech story yesterday: Is it human, animal or plant? At Bayer, they're mixing all three in new R&D recipe. More | Follow @JohnCFierce

@DamianFierce: The long, strange trip that was Wright Medical's 2013. Report | Follow @DamianFierce

@EmilyMFierce: Cancer Research UK to repurpose an AstraZeneca asthma drug for kidney cancer. Story from FierceBiotech Research | Follow @EmilyMFierce

> Ambitious HDL program joins a growing list of high-profile clinical failures. Story

> A step ahead of controversial transparency rules, Sanofi commits to open access. Report

> NeXeption raises $21.5M to launch dermatology startup Alexar. Article

And Finally... A new report on opioid pain drugs faults many developing countries for restricting their use to stop abuse, saying it is causing a global pain pandemic. Story

Suggested Articles

In previously untreated nonsquamous NSCLC, a Tyvyt-chemo combo beat chemo alone at stalling the time to tumor progression or death.

It’s been a big year for Bristol's Opdivo-Yervoy combo in lung cancer, but with new mesothelioma data in hand, the duo isn’t done making headlines.

A third spinal muscular atrophy treatment option is set to debut with the FDA’s approval for Roche’s Evrysdi, formerly known as risdiplam.